Share Price:

APNASPENAspen Pharmacare Hldgs21603-28 (-0.13%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Aspen presented with the Ubuntu Economic Diplomacy (Africa) Award

Cape Town – JSE Limited-listed Aspen Pharmacare (APN), South Africa’s largest pharmaceutical company, was presented with the Economic Diplomacy (Africa) Award by the South African Government at the prestigious 4th annual Ubuntu Awards, held in Cape Town on 22 March 2018. Accepting the award from Lindiwe Sisulu, Minister of International Relations and Cooperations (“Dirco”) on… Continue reading Aspen presented with the Ubuntu Economic Diplomacy (Africa) Award

Aspen delivers double digit revenue and earnings growth

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a leading global pharmaceutical company, has announced favourable results for the six months ended 31 December 2017. Aspen Interim Results release March 2018

CNBC Exclusive with Aspen CEO Stephen Saad

Aspen Pharmacare billionaire Steven Saad opens up with the inside story of the fall of his shares. Exclusive on CNBC Africa first in business worldwide. CNBC Exclusive with Aspen CEO Stephen Saad from Aspen Pharmacare Pty Limited on Vimeo.

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.